Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation
Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo
Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo
View: Text | PDF
Research Article Cardiology Vascular biology

Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation

  • Text
  • PDF
Abstract

The endocardium is a major source of coronary angiogenesis and arterialization, through coordinated cell fate transition and migration. However, the transcriptional regulatory network synchronizing cell fate determination and movement remains unclear. Here, we identified transcription factor HAND2 as a key candidate for coronary vascular formation. Endocardial deletion of Hand2 in mice disrupted arterial-venous networks and stunted coronary arteries, paralleling a ventricular noncompaction phenotype. Moreover, deletion of Hand2 produced excessive tip cells with defective movement. RNA-seq analysis revealed enhanced hypoxic metabolic activation but declined TGF-β/p38MAPK–dependent endothelial-mesenchymal transition. In contrast, genetic inhibition of the core hypoxic regulators or pharmaceutical administration of TGF-β2 partially recovered the coronary arterial defects in Hand2 mutants. Furthermore, HAND2 was found to directly bind to promoters of the target genes, harmonizing cell migration and cell fate transition. These findings pinpoint HAND2 as an essential regulator of the endocardial transcriptional regulatory network for coronary arterialization and provide potential therapeutic targets for coronary artery diseases.

Authors

Huijuan Wang, Haosheng Zhang, Leiyin Zheng, Peihan Zhang, Yuqian Wang, Sijia Ding, Wenping Liu, Yuanming Cheng, Zhongzhou Yang, Wen Luo

×

Figure 5

Hand2 deficiency in endothelium elevated hypoxia signaling and enhanced tip cell activity.

Options: View larger image (or click on image) Download as PowerPoint

Hand2 deficiency in endothelium elevated hypoxia signaling and enhanced...
(A) Representative images and quantitative analysis of hypoxia response factors HIF1α and HIF2α in E15.5 Hand2-EKO hearts. n = 3 hearts per group. (B) qPCR analysis of hypoxia-associated genes from ECs of E15.5 Hand2-EKO hearts. n = 3 samples per group. (C) Confocal images showing upregulated downstream targets, including GLUT1, ENO1, HK2, LDHA, PDK1, and TPI in Hand2 mutants. n = 3 hearts per group. (D) qPCR analysis of glycolysis-associated genes from ECs of E15.5 Hand2-EKO hearts. n = 3 samples per group. (E) Schematic illustration of strategies of EMCN+ endocardial cells sorting for qPCR analysis. (F) qPCR analysis of tip cell–enriched genes from EMCN+ ECs of E14.5 hearts. n = 3 samples per group. (G) Immunostaining of tip cell markers, such as ANGPT2, vWF, and CAV1, showing increased expression in endocardium. n = 3 hearts per group. (H) Whole-mount staining showing the partial rescue in coronary arteries after suppressing Hif pathway in Hand2-EKO hearts with quantification analysis. n = 6 hearts per group. The width of myocardial region and quantification analysis of JAG1+ arterial vessels of each group. n = 3 hearts per group. Data represent mean ± SEM. Statistical significance was assessed using an unpaired 2-tailed Student’s t test (A, B, D and F) or 1-way ANOVA (H) followed by Tukey’s multiple-comparison test. *P < 0.05, **P < 0.01, ***P < 0.001. Scale bars: 100 μm (A, C, G and H).

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts